Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Vaccines|October 21, 2020
Selecting Target Antigens for Cancer Vaccine DevelopmentLuigi Buonaguro, Maria Tagliamonte
Frontiers in Immunology|November 15, 2023
Corrigendum: Peptide-based vaccine for cancer therapiesLuigi Buonaguro, Maria Tagliamonte
Frontiers in Immunology|September 1, 2023
Peptide-based vaccine for cancer therapiesLuigi Buonaguro, Maria Tagliamonte
Frontiers in Oncology|November 4, 2022
The impact of antigenic molecular mimicry on anti-cancer T-cell immune responseMaria Tagliamonte, Luigi Buonaguro
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2013
Chemokine receptor interactions with virus-like particlesLuigi Buonaguro, Maria Tagliamonte, Maria Luisa Visciano
The New Microbiologica|February 27, 2007
Evolution of the HIV-1 V3 region in the Italian epidemicLuigi Buonaguro, Maria Tagliamonte, Marialina Tornesello, et al.
Cellular and Molecular Life Sciences : CMLS|August 5, 2019
Dual CCR5/CCR2 targeting: opportunities for the cure of complex disordersLaura Fantuzzi, Maria Tagliamonte, Maria Cristina Gauzzi, et al.
Annals of Hepatology|May 4, 2019
Immunotherapy in hepatocellular carcinomaLuigi Buonaguro, Angela Mauriello, Beatrice Cavalluzzo, et al.
Journal of Translational Medicine|May 7, 2020
SARS-CoV-2 RNA polymerase as target for antiviral therapyLuigi Buonaguro, Maria Tagliamonte, Maria Lina Tornesello, et al.
Journal of Virological Methods|January 25, 2005
Evaluation of a modified version of Heteroduplex Mobility Assay for rapid screening of HIV-1 isolates in epidemics characterized by mono/dual clade predominanceLuigi Buonaguro, Maria Tagliamonte, Maria Lina Tornesello, et al.
Pageof 7